Replies to post #203352 on Biotech Values

[swampboots]

MSLI.....Hardly followed stock ( or roll-up) on I-Hub.... anyone know if any of their acquisitions will turn into monster "leavings"....on the face of it their debt seems high? Yet this poster is a steady DD spelunker ( and "stat head"), so I am sort of interested in not discarding any possible overlooked gem.

[SSKILLZ1]

MSLI

in my opinion this quarter was very much a disappointment based on guidence, and I will be selling out. I may buyback in 3 months depending how low the stock gets, but right now hard to see upside, because what I didn't like is management announced and update on July 1rst at reiterating the 47-50 million in EBITDA, now it down to 43-46 million, the quarter was allready over they should of known they weren't gonna hit their guidence July 1rst in my opinion. I wonder if they lower it again, hence I will sell and move on. All is just my opinion, and I could always be wrong though.